J. Dartsch

Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype

E. Klopocki, J. Kühnisch, S. Störk, 2019, Human mutation.

RIKADA Study Reveals Risk Factors in Pediatric Primary Cardiomyopathy

D. Messroghli, T. Kuehne, J. Kühnisch, 2019, Journal of the American Heart Association.

Transmission ratio distortion of mutations in the master regulator of centriole biogenesis PLK4

D. Horn, M. Holtgrewe, K. Sperling, 2022, Human Genetics.

Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis—Further Impact of Heterozygous Immune Disorder Gene Variants?

M. Holtgrewe, D. Beule, K. Klingel, 2022, Journal of cardiovascular development and disease.

Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3

M. Holtgrewe, D. Beule, D. Messroghli, 2019, Clinical genetics.

Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy

J. Kühnisch, F. Berger, E. Oechslin, 2021, Frontiers in Pediatrics.

Prdm16 mutation determines sex-specific cardiac metabolism and identifies two novel cardiac metabolic regulators

B. Obermayer, D. Beule, N. Hubner, 2023, bioRxiv.

Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis

M. Holtgrewe, D. Beule, D. Messroghli, 2021, Circulation. Genomic and precision medicine.